Assertio Therapeutics (ASRT) PT Raised to $10 at BWS Financial
Tweet Send to a Friend
BWS Financial analyst Hamed Khorsand raised the price target on Assertio Therapeutics (NASDAQ: ASRT) to $10.00 (from $8.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
